Nicolas Magne

Impact of hyperthermic intraperitoneal chemotherapy on Hsp27 protein expression in serum of patients with peritoneal carcinomatosis.

Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma.

Nanoparticles in radiation oncology: From bench-side to bedside.

Conflict of interests for radiation oncologists: Harnessing disclosures from policy to reality.

Radiotherapy for gynecologic cancer in nonagenarian patients: a framework for new paradigms.

[Rhabdomyosarcoma of adult genital tract: A short review].

[Hyperbaric oxygen and radiotherapy: From myth to reality].

Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC).

[Radiotherapy phase I trials' methodology: Features].

[Prostate cancer of elderly patients: Place and role of geriatric assessment].

Immunotherapy in head and neck cancer: Harnessing profit on a system disruption.

[Reappraisal role of locoregional radiation therapy in metastatic cancers].

[Care of Merkel cell carcinoma and role of the radiotherapy].

[50th anniversary of cisplatin].

Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma.

Melanoma: Last call for radiotherapy.

Preclinical models in HNSCC: A comprehensive review.

[Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].

HPV-16 variants' impact on uterine cervical cancer response to radiotherapy: A descriptive pilot study.

Differential pattern of HIF-1α expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.

[Immunotherapy: Activation of a system not a pathway].

Brain metastases from non-small cell lung carcinoma: Changing concepts for improving patients' outcome.

Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?

Gadolinium-based nanoparticles as sensitizing agents to carbon ions in head and neck tumor cells.

Dual "mAb" HER family blockade in head and neck cancer human cell lines combined with photon therapy.